Swann R A, Clark J
Public Health Laboratory, Leicester Royal Infirmary NHS Trust, UK.
J Antimicrob Chemother. 1994 May;33 Suppl A:131-5. doi: 10.1093/jac/33.suppl_a.131.
In the UK rational antimicrobial prescribing in General Practice requires effective communication between the Family Health Services Authority (FHSA), microbiologists and General Practitioners (GPs). Many FHSAs now have a Pharmaceutical Adviser to assist the FHSA Medical Adviser in providing pharmaceutical advice, setting and monitoring of indicative prescribing amounts and fundholding drug budgets. They are also increasingly involved in developing practice formularies. Reviews of local prescribing often show significant differences between antimicrobial usage and local recommendations from microbiologists which are generally based on their interpretation of local laboratory susceptibility data. The efforts of two FHSAs working with local microbiologists to communicate a rational antimicrobial policy are described. This has involved conducting prescribing audit, publishing guidelines, practice visits and arranging meetings between GPs, microbiologists and FHSA staff.
在英国,全科医疗中合理使用抗菌药物需要家庭健康服务管理局(FHSA)、微生物学家和全科医生(GP)之间进行有效的沟通。现在许多家庭健康服务管理局都有一名药学顾问,协助家庭健康服务管理局的医学顾问提供药学建议、设定和监测指示性处方量以及管理药品预算。他们还越来越多地参与制定医疗机构处方集。对当地处方的审查往往表明,抗菌药物的使用情况与微生物学家的当地建议存在显著差异,而这些建议通常是基于他们对当地实验室药敏数据的解读。本文描述了两个家庭健康服务管理局与当地微生物学家合作传达合理抗菌政策的努力。这包括进行处方审核、发布指南、开展实践访问以及安排全科医生、微生物学家和家庭健康服务管理局工作人员之间的会议。